Thromb Haemost 1990; 63(02): 235-240
DOI: 10.1055/s-0038-1645201
Original Article
Schattauer GmbH Stuttgart

Expression of Functional Coagulation Factor XIII in Escherichia coli

P G Board
The Human Genetics Group, John Curtin School of Medical Research, Australian National University, Canberra, Australia
,
K Pierce
The Human Genetics Group, John Curtin School of Medical Research, Australian National University, Canberra, Australia
,
M Coggan
The Human Genetics Group, John Curtin School of Medical Research, Australian National University, Canberra, Australia
› Author Affiliations
Further Information

Publication History

Received 06 October 1989

Accepted after revision 27 December 1989

Publication Date:
02 July 2018 (online)

Summary

Coagulation factor XIII is a zymogen that can be activated by thrombin cleavage to a transglutaminase that catalyses the formation of covalent crosslinks between fibrin chains in the final stages of the blood clotting cascade. Although circulating factor-XIII is composed of A and B subunits the catalytic activity is a property of the A subunits. In this study we have constructed a plasmid (pKKF13A) that contains a cDNA encoding the A subunit positioned downstream of a tac promoter. Escherichia coli containing this plasmid produce A subunit protein when grown in the presence of IPTG. The cloned A subunit has been partially purified and characterized. Comparison with A subunits purified from plasma showed that the cloned A subunits were of the same size, assembled as dimers, and had the same native electrophoretic mobility. The cloned A subunits expressed transglutaminase activity with putrescine, dansylcadaverine and casein as substrates, and were able to crosslink fibrin in clots formed from A subunit deficient plasma. These studies have demonstrated that functional recombinant factor XIII A subunit can be produced in E. coli and suggest that recombinant factor XIII can potentially provide a safe and inexhaustible supply for therapeutic use.

 
  • References

  • 1 Lorand L, Losowsky MS, Miloszewski KJ M. Human factor XIII fibrin-stabilizing factor. Prog Hemostasis Thromb 1980; 5: 245-290
  • 2 Mosher DF, Schad PE, Vann JM. Cross linking of collagen and fibronectin. J Biol Chem 1980; 255: 1181-1188
  • 3 Schwartz ML, Pizzo SV, Hill RL, McKee PA. Human factor XIII from plasma and platelets. J Biol Chem 1973; 248: 1395-1407
  • 4 Board PG. Genetic polymorphism of the B subunit of coagulation factor XIII. Am J Hum Genet 1980; 32: 348-353
  • 5 Ichinose A, Hendrickson LE, Fujikawa K, Davie EW. The amino acid sequence of the A subunit of human factor XIII. Biochemistry 1986; 25: 6900-6906
  • 6 Gundman U, Amann E, Zettlmeissl G, Küpper HA. Characterization of a cDNA coding for human factor XHIa. Proc Natl Acad Sci USA 1986; 83: 8024-8028
  • 7 Ichinose A, McMullen BA, Fujikawa K, Davie EW. Amino acid sequence of the B subunit of human factor XIII, a protein composed of ten repetati.ve segments. Biochemistry 1986; 25: 4633-4638
  • 8 Mary A, Achyuthan KE, Greenberg CS. b-Chains prevent proteolytic inactivation of the a-chains of plasma factor XIII Biochem Biophys Acta 1988; 966: 328-335
  • 9 Board PG, Reid M, Serjeantson S. The gene for coagulation factor XIII a subunit (F13A) is distal to HLA on chromosome 6. Hum Genet 1984; 67: 406-408
  • 10 Weisberg LJ, Shiu DT, Greenburg CS, Kan YW, Shuman MS. Localization of the gene for coagulation factor XIII a chain to chromosome 6 and identification of sites of synthesis. J Clin Invest 1987; 79: 649-652
  • 11 Board PG, Webb GC, McKee J. Ichinose A. Localization of the coagulation factor XIIIA subunit gene (F13A) to chromosome bands 6p 24 → p 25. Cytogenet and Cell Genet 1988; 48: 25-27
  • 12 Webb GC, Coggan M, Ichinose A, Board PG. Localization of human coagulation factor XI1IB subunit gene (F13B) to chromosome bands lq31-32.1 and restriction fragment polymorphism of the locus. Human Genet 1989; 81: 157-160
  • 13 Duckert F, Jung E, Schmerling DH. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thromb Diath Haemorrh 1960; 5: 179-186
  • 14 Castle S, Board PG, Anderson RAM. Genetic heterogeneity of factor XIII deficiency; first description of unstable subunits. Br J Haematol 1981; 48: 337-342
  • 15 Castle S, Board PG. Biochemical characterization of genetically variant and abnormal blood coagulation factor XIII A subunits. Clin Chim Acta 1983; 133: 141-151
  • 16 Takahashi N, Takahashi Y, Putnam FW. Primary structure of blood coagulation factor XIII a (fibrinoligase, transglutaminase) from human placenta. Proc Natl Acad Sci USA 1986; 83: 8019-8023
  • 17 Board PG, Pierce K. Expression of human glutathione S-transferase 2 in Escherichia coli: Immunological comparison with the basic glutathione S-transferase from human liver. Biochem J 1987; 248: 937-941
  • 18 Coggan M, Board PG. A fluorescent spot test for coagulation factor XIII. Anal Biochem 1984; 137: 402-404
  • 19 Board PG. Genetic polymorphism of the A subunit of human coagulation factor XIII. Am J Hum Genet 1979; 31: 116-124
  • 20 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-681
  • 21 Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and application. Proc Natl Acad Sci USA 1979; 76: 4350-4354
  • 22 Schwartz ML, Pizzi S, Hill R, McKee P. The subunit structures of human plasma and platelet factor XIII (fibribn stabilizing factor). J Biol Chem 1971; 246: 5851-5854
  • 23 McDonagh J, Waggoner WG, Hamilton EG, Hindenach B, McDonagh RP. Affinity chromatography of human plasma and platelet factor XIII on organomercurial agarose. Biochim Biophys Acta 1976; 446: 345-357
  • 24 Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem 1987; 262: 10035-10038
  • 25 Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467
  • 26 Norrander J, Kempt T, Messing J. Construction of improved M13 vectors using oligodeoxynucleotide-directed mutagenesis. Gene 1983; 26: 101-106
  • 27 Takagi T, Dollittle RF. Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin. Biochemistry 1974; 13: 750-756
  • 28 Shine J, Dalgerno L. Determinant of cistron specificity in bacterial ribosomes. Nature 1975; 254: 34-38
  • 29 Bohn H. The human fibrin-stabilizing factors. Mol Cell Biochem 1978; 20: 67-75
  • 30 Dvilansky A, Britten AF H, Loewy AG. Factor XIII assay by an isotope method. I. Factor XIII (transamidase) in plasma, serum, leukocytes, erythrocytes and platelets and evaluation of screening tests for clot solubility. Br J Haematol 1970; 18: 399-410
  • 31 Lorand L, Campbell LK. Transamidating enzymes 1. Rapid chromatographic assays. Annal Biochem 1971; 44: 207-220
  • 32 Amann E, Ochs B, Abel KJ. Tightly regulated tac promoter vectors useful for expression of unfused and fused proteins in Escherichia coli. Gene 1988; 69: 301-315
  • 33 Amann E, Abel KJ, Grundmann U, Okazaki H, Kiipper HA. Synthesis of human factor XIIIa in bacterial cells. Behring Inst Mitt 1988; 82: 35-42
  • 34 Bröker M, Karges HE. Expression of human factor XIIIA in yeast. Yeast 1988; 4: 142
  • 35 Bröker M, BUuml O. New expression vectors tor the fission yeast Schizosaccharomyces pombe. FEBS Let 1989; 248: 105-110
  • 36 Hornyak TJ, Bishop PD, Shafer JA. α-Thrombin-catalyzed activation of human platelet factor XIII: Relationship between proteolysis and factor XIIIa activity. Biochemistry 1989; 28: 7326-7332